Shay Capital »

Akero Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $303k 12k 25.26

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alibaba Group Hldg Sponsored Ads (BABA)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Datadog Cl A Com (DDOG)
Viking Therapeutics (VKTX)
Golar Lng SHS (GLNG)
Endeavor Group Hldgs Cl A Com (EDR)
Tillys Cl A (TLYS)
Baidu Spon Adr Rep A (BIDU)
Genworth Finl Com Cl A (GNW)
Snowflake Cl A (SNOW)
Mbia (MBI)
Turtle Beach Corp Com New (HEAR)
Advanced Micro Devices (AMD)

View all positions for Shay Capital

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Redmile Group
Boxer Capital
Alliancebernstein
Yiheng Capital
Geode Capital Management
Perceptive Advisors
Fred Alger Management
Rock Springs Capital Management

View all funds holding Akero Therapeutics